Cell-free hemoglobins, chemically altered or genetically expressed in microbial host systems, have been developed as oxygen-carrying therapeutics. Site-directed modifications are introduced and serve to stabilize the protein molecules in a tetrameric and/or a polymeric functional form. Animal studies, as well as recent clinical studies, have suggested these proteins probably deliver oxygen to tissues. However, concerns still persist regarding the interference of hemoglobin and its oxidation products with the vascular redox balance, potentially impeding its clinical usefulness. This article reviews our current understanding of heme-mediated toxicities and some of the emerging protective strategies used to overcome hemoglobin side reactions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/10715760000300881 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A New Oxygen Carrier for Therapeutic Applications.
Drug Test Anal
January 2025
Hemarina SA, Aeropôle Centre, Morlaix, France.
The natural extracellular hemoglobin of the lugworm Arenicola marina (AmHb) has many interesting characteristics: It carries 40 times more oxygen than human hemoglobin; has anti-inflammatory, antibacterial, and antioxidant properties; and is 250 times smaller than a red blood cell. It is nontoxic and nonimmunogenic. It is thus a very promising hemoglobin-based oxygen carrier.
View Article and Find Full Text PDFHemoglobin-based oxygen carriers: Biochemical, biophysical differences, and safety.
Transfusion
January 2025
Office of Blood Research and Review, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland, USA.
Development of hemoglobin microbubbles for acoustic blood oxygen sensing: A study on PEGylation and gas core modification for in vivo applications.
Acta Biomater
December 2024
Department of Bioengineering, Erik Johnson School of Engineering, The University of Texas at Dallas. Electronic address:
The creation of innovative ultrasound contrast agents (UCAs) with the ability to monitor oxygen levels in real-time holds immense potential for advancing early diagnosis of various medical conditions such as hypoxic/reperfusion injury. In this study, we propose the development of oxygen sensitive UCAs using microbubbles composed of hemoglobin (HbMBs), which can function as sensors for blood oxygen levels. Previously, we performed a study highlighting the initial proof-of-concept efficacy of air-filled HbMBs in detecting oxygenation changes in vitro, offering a promising tool for clinically detecting tissue hypoxia.
View Article and Find Full Text PDFArtificial blood-hope and the challenges to combat tumor hypoxia for anti-cancer therapy.
Med Biol Eng Comput
November 2024
Amity Stem Cell Institute, Amity Medical School, Amity University Haryana, Amity Education Valley, Panchgaon, Manesar (Gurugram), Haryana, 122413, India.
Article Synopsis
- - Blood is essential for the body, transporting hormones, regulating temperature and pH, and playing a key role in immune defense and healing through white blood cells and platelets.
- - The circulatory system, made up of arteries, veins, and capillaries, ensures the efficient delivery of nutrients and oxygen but often faces challenges like shortages and compatibility issues, making artificial blood alternatives important.
- - Our study focused on using artificial blood, including red blood cell substitutes and artificial platelets, to improve cancer therapy by addressing issues like tumor hypoxia and enhancing treatment outcomes.
In vitro and in vivo investigations of hemoglobin-loaded PEGylated ZIF-8 nanoparticles as oxygen carriers for emergency transfusion.
Biomater Adv
March 2025
Department of Health Technology, Technical University of Denmark, Kgs. Lyngby 2800, Denmark. Electronic address:
The limitations of traditional blood supply systems, particularly where ideal storage is unfeasible, challenge the efficacy of transfusion medicine, especially in emergencies and battlefield scenarios. This study investigates a novel hemoglobin-based oxygen carrier (HBOC) using a dual-coating approach with metal phenolic networks (MPNs) and polyethylene glycol (PEG). Utilizing zeolitic imidazolate framework-8 (ZIF-8) nanoparticles for their porosity and biocompatibility, the addition of MPN and PEG coatings enhances biocompatibility and stabilizes encapsulated hemoglobin (Hb).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!